Validation of a Short Physical Activity Questionnaire (Work and Leisure)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Clermont-Ferrand

About this trial

Validated physical activity questionnaires are often long and time-consuming, particularly when assessing both leisure-time and occupational physical activity and sedentary behavior.

The ACTIWORK study aims to validate a short questionnaire assessing physical activity at work and during leisure time, as well as sedentary behavior, by comparison with the reference Recent Physical Activity Questionnaire (RPAQ).

Participants will complete the study questionnaires twice, approximately one week apart, to assess the consistency of their responses over time.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Any person volunteering to participate in the study

Disqualifiers

Person not willing to participate in the study.

Trial population

Volunteers from the general population recruited through paper questionnaires and electronic distribution using REDCap®, including anonymous mailing lists, social networks, flyers, and other public distribution channels

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • ACTIWORK questionnaire

    Other intervention

    Short questionnaire assessing physical activity and sedentary behavior, including leisure-time and occupational physical activity, sitting time, and work-related characteristics. The questionnaire is administered twice, approximately one week apart, for test-retest assessment.

  • Recent Physical Activity Questionnaire (RPAQ)

    Other intervention

    Reference questionnaire assessing physical activity during the previous four weeks, including physical activity at home, at work, during commuting, and during leisure time. The RPAQ is administered twice, approximately one week apart.

  • REPEAS questionnaire

    Other intervention

    Questionnaire assessing environmental and personal barriers to regular physical activity. The questionnaire includes 12 items covering environmental and personal factors that may limit regular physical activity and is administered twice, approximately one week apart.

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: Volunteers from general population3 interventions

Trial outcomes

Primary outcomes

1

Working time assessed by ACTIWORK

Working time assessed using the ACTIWORK questionnaire, expressed as hours per week and hours per working day.

Time frame
Baseline and 1 week
2

Leisure-time physical activity assessed by ACTIWORK

Time spent in leisure-time physical activity assessed using the ACTIWORK questionnaire, expressed as hours per week.

Time frame
Baseline and 1 week
3

Physical activity intensity assessed by ACTIWORK

Perceived intensity of physical activity during leisure time and at work, assessed using visual analog scales ranging from 0 (minimum intensity) to 100 (maximum intensity) .

Time frame
Baseline and 1 week
4

Daily sitting time assessed by ACTIWORK

Total time spent sitting per day, assessed using the ACTIWORK questionnaire and expressed in hours per day.

Time frame
aseline and 1 week

Secondary outcomes

1

Recent Physical Activity Questionnaire (RPAQ)

Physical activity assessed using the reference Recent Physical Activity Questionnaire (RPAQ), covering physical activity at home, at work, during commuting, and during leisure time over the previous four weeks.

Time frame
Baseline and 1 week
2

REPEAS questionnaire

Environmental and personal barriers to regular physical activity assessed using the 12-item REPEAS questionnaire. Each barrier is rated using a visual analog scale ranging from minimum (0) to maximum (100) difficulty.

Time frame
Baseline and 1 week
3

Age

Age of the participant, expressed in years

Time frame
Baseline
4

Gender

Gender of the participant, categorized as female or male

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.